Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabozantinib in HCC Patients Post-Immunotherapy
NCT04435977Phase 2Unknown
- Sponsor
- Humanitas Research Hospital
- Start
- Jan 2020
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabozantinib in hepatocellular carcinoma (HCC), sponsored by Humanitas Research Hospital. Status: unknown.
02
Drugs
cabozantinib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT04435977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04435977.